ScoreWhy is Wanbangde Pharmaceutical Holding Group Co., Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -36.85% and Operating profit at -150.12% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 5.44% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -36.85% and Operating profit at -150.12% over the last 5 years
3
Flat results in Mar 26
- NET SALES(HY) At CNY 473.83 MM has Grown at -30.72%
- NET PROFIT(HY) At CNY -76.34 MM has Grown at -411.07%
- ROCE(HY) Lowest at -3%
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 65.81%, its profits have fallen by -418%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Wanbangde Pharmaceutical Holding Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Wanbangde Pharmaceutical Holding Group Co., Ltd.
-0.98%
2.31
69.18%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-36.85%
EBIT Growth (5y)
-150.12%
EBIT to Interest (avg)
3.26
Debt to EBITDA (avg)
4.04
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.38
Tax Ratio
52.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.16%
ROE (avg)
5.44%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.61
EV to EBIT
-590.82
EV to EBITDA
95.89
EV to Capital Employed
2.37
EV to Sales
6.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.40%
ROE (Latest)
-3.56%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 618.17 MM
NET PROFIT(HY)
Higher at CNY 64.97 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 19.53 %
DEBTORS TURNOVER RATIO(HY)
Highest at 1.29 times
-26What is not working for the Company
NET SALES(Q)
At CNY 214.6 MM has Fallen at -27.03%
PRE-TAX PROFIT(Q)
At CNY -58.01 MM has Fallen at -259.94%
NET PROFIT(Q)
At CNY -37.98 MM has Fallen at -68.92%
RAW MATERIAL COST(Y)
Grown by 14.09% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.03 times
INTEREST(Q)
Highest at CNY 12.98 MM
Here's what is working for Wanbangde Pharmaceutical Holding Group Co., Ltd.
Debt-Equity Ratio
Lowest at 19.53 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Cash Flow
Highest at CNY 618.17 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Debtors Turnover Ratio
Highest at 1.29 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Wanbangde Pharmaceutical Holding Group Co., Ltd.
Net Sales
At CNY 214.6 MM has Fallen at -27.03%
over average net sales of the previous four periods of CNY 294.11 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY -58.01 MM has Fallen at -259.94%
over average net sales of the previous four periods of CNY -16.12 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -37.98 MM has Fallen at -68.92%
over average net sales of the previous four periods of CNY -22.48 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 12.98 MM has Grown at 21.55%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest
Highest at CNY 12.98 MM
in the last five periods and Increased by 21.55% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Inventory Turnover Ratio
Lowest at 3.03 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Raw Material Cost
Grown by 14.09% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
